Cite
HARVARD Citation
Salehi, A. et al. (2022). Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial. Psychiatry research. p. . [Online].